Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0K2PH
|
||||
| Former ID |
DNC000601
|
||||
| Drug Name |
Elvucitabine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26] | Discontinued in Phase 2 | [546317] | ||
| Formula |
C9H10FN3O3
|
||||
| Canonical SMILES |
C1=CC(OC1CO)N2C=C(C(=NC2=O)N)F
|
||||
| InChI |
1S/C9H10FN3O3/c10-6-3-13(9(15)12-8(6)11)7-2-1-5(4-14)16-7/h1-3,5,7,14H,4H2,(H2,11,12,15)/t5-,7+/m1/s1
|
||||
| InChIKey |
HSBKFSPNDWWPSL-VDTYLAMSSA-N
|
||||
| CAS Number |
CAS 181785-84-2
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | HIV reverse transcriptase | Target Info | Modulator | ||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.